drugset / Trial / NCT00302731
Bioidentical 'Natural' Hormone Evaluation in Early Menopause
Phase 2
Terminated
21 enrolled
Jeanne Drisko, MD, CNS, FACN
Private Foundation through KU Endowment · collabUniversity of Kansas · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Prospective double blind pilot study comparing bioidentical 'natural' hormones to low-dose PremPro. Forty participants will be enrolled. The purpose of this study is to try to gather early information about safety when "natural" or bioidentical hormones are used during early menopause.
Timeline
- Start
- 2006-02
- Primary completion
- 2014-01
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | ESTROGENS, CONJUGATED | Unknown | 0.45 mg | — |
| Subject | Estradiol | Other / unclassified | 0.5 mg | Oral |
| Subject | Estriol | Unknown | 2 mg | Oral |
| Subject | Estriol | Unknown | 2.5 mg | Oral |
| Subject | Progesterone | Other / unclassified | 100 mg | Oral |
| Comparator | medroxyprogesterone acetate | Other / unclassified | 1.5 mg | — |